OncoMed Pharmaceuticals, Inc. Net Income 2013-2018 | OMED
OncoMed Pharmaceuticals, Inc. net income from 2013 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| OncoMed Pharmaceuticals, Inc. Annual Net Income (Millions of US $) |
|
|---|---|
| 2018 | $-8 |
| 2017 | $-39 |
| 2016 | $-103 |
| 2015 | $-85 |
| 2014 | $-50 |
| 2013 | $-26 |
| 2012 | $-22 |
| 2011 | $-15 |
| 2010 | $-27 |
| OncoMed Pharmaceuticals, Inc. Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2018-12-31 | $-5 |
| 2018-09-30 | $6 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $9 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-23 |
| 2016-12-31 | $-22 |
| 2016-09-30 | $-26 |
| 2016-06-30 | $-28 |
| 2016-03-31 | $-27 |
| 2015-12-31 | $-25 |
| 2015-09-30 | $-24 |
| 2015-06-30 | $-22 |
| 2015-03-31 | $-15 |
| 2014-12-31 | $-15 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-16 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-10 |
| 2013-03-31 | $-9 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-4 |
